文献速递消化道肿瘤与早癌消化内镜

腺瘤检出率与腺瘤特征对筛查结肠镜后结直肠癌死亡率的影响

Association of Adenoma Detection Rate and Adenoma Characteristics With Colorectal Cancer Mortality After Screening Colonoscopy.
PubMed 文献 · Clin Gastroenterol Hepatol · 2021-04-18

基于奥地利筛查结肠镜质量保障计划数据,评估腺瘤检出率(ADR)与既往切除腺瘤特征对结直肠癌(CRC)死亡率的联合影响。研究纳入259,885例结肠镜,由361名内镜医师完成,随访至12.2年,发生165例CRC相关死亡。结果显示,在高风险腺瘤患者中,由ADR<25%的内镜医师操作时CRC死亡风险显著增加(调整HR 2.25,95%CI 1.18-4.31),而ADR≥25%时风险无显著增加。

要点

  • ADR<25%的内镜医师操作时,高风险腺瘤患者CRC死亡风险显著增加。
  • 低风险腺瘤患者CRC死亡率与ADR水平无关。
  • 高质量结肠镜(ADR≥25%)与降低CRC死亡风险相关,尤其对高风险腺瘤患者。

核心结论

  • 高质量结肠镜(ADR≥25%)与降低CRC死亡风险相关,ADR的影响在高风险腺瘤个体中最强。

研究设计与样本

  • 基于奥地利筛查结肠镜质量保障计划数据的回顾性队列研究,纳入259,885例结肠镜,由361名内镜医师完成。

主要发现

  • 随访至12.2年,共发生165例CRC相关死亡。
  • 所有风险组中,由ADR<25%的内镜医师操作时CRC死亡率更高。
  • 高风险腺瘤患者由ADR<25%医师操作时CRC死亡风险显著增加(调整HR 2.25,95%CI 1.18-4.31),由ADR≥25%医师操作时无显著增加(调整HR 1.35,95%CI 0.61-3.02)。
  • 低风险腺瘤患者CRC死亡率与ADR无关(ADR≥25%:调整HR 1.22,95%CI 0.59-2.49;ADR<25%:调整HR 1.25,95%CI 0.64-2.43)。
  • 阴性结肠镜后由ADR<25%医师操作时CRC死亡风险无显著增加(调整HR 1.27,95%CI 0.81-2.00)。

临床怎么用

  • 应强制评估和监测筛查结肠镜的质量,尤其关注内镜医师的ADR。
  • 对于高风险腺瘤患者,确保其结肠镜检查由ADR≥25%的内镜医师完成可能降低CRC死亡风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: The adenoma detection rate (ADR) and characteristics of previously resected adenomas are associated with colorectal cancer (CRC) incidence and mortality. However, the combined effect of both factors on CRC mortality is unknown. PATIENTS AND METHODS: Using data of the Austrian quality assurance program for screening colonoscopy, we evaluated the combined effect of ADR and lesion characteristics on subsequent risk for CRC mortality. We analyzed mortality rates for individuals with low-risk adenomas (1-2 adenomas <10 mm), individuals with high-risk adenomas (advanced adenomas or ≥3 adenomas), and after negative colonoscopy (negative colonoscopy or small hyperplastic polyps) performed by endoscopists with an ADR <25% compared with ≥25%. Cox regression was used to determine the association of combined risk groups with CRC mortality, adjusted for age and sex. RESULTS: We evaluated 259,885 colonoscopies performed by 361 endoscopists. A total of 165 CRC-related deaths occurred during the follow-up period, up to 12.2 years. In all risk groups, CRC mortality was higher when colonoscopy was performed by an endoscopist with an ADR <25%. Compared with negative colonoscopy with an ADR ≥25%, CRC mortality was similar for individuals with low-risk adenomas irrespective of ADR (for ADR ≥25%: adjusted hazard ratio [HR], 1.22; 95% confidence interval [CI], 0.59-2.49; for ADR <25%: adjusted HR, 1.25; 95% CI, 0.64-2.43) and after negative colonoscopy with ADR <25% (adjusted HR, 1.27; 95% CI, 0.81-2.00). Individuals with high-risk adenomas were at significantly higher risk for CRC death if colonoscopy was performed by an endoscopist with an ADR <25% (adjusted HR, 2.25; 95% CI, 1.18-4.31) but not if performed by an endoscopist with an ADR ≥25% (adjusted HR, 1.35; 95% CI, 0.61-3.02). CONCLUSIONS: Our study adds important evidence for mandatory assessment and monitoring of performance quality in screening colonoscopy. High-quality colonoscopy was associated with a lower risk for CRC death, and the impact of ADR was strongest for individuals with high-risk adenomas.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Waldmann E, Kammerlander AA, Gessl I, et al. Association of Adenoma Detection Rate and Adenoma Characteristics With Colorectal Cancer Mortality After Screening Colonoscopy. Clin Gastroenterol Hepatol. 2021. PMID: 33878471. doi:10.1016/j.cgh.2021.04.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。